Why the study?
Do various lifestyle, pharmacological, and procedural therapeutic modifications improve arterial stiffness in patients at high cardiovascular risk?
Population
Patients at high cardiovascular risk, including those with hypertension, metabolic syndrome, diabetes…
Design
Review
Authors
Loading...
Multimodal risk factor modification may improve arterial stiffness; leaves open effects on clinical outcomes pending prospective trials.
Do various lifestyle, pharmacological, and procedural therapeutic modifications improve arterial stiffness in patients at high cardiovascular risk?
This comprehensive review highlights that arterial stiffness, a marker of cardiovascular disease, can be improved through various lifestyle, pharmacological, and procedural interventions tailored to specific patient populations.
Ching-Fen Wu (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: